Crossref
Economic Assessment of Novel Gene and Cellular Therapies: Beyond Traditional Modeling
Journal of Clinical Pathways · 2018
DOI: 10.25270/jcp.2018.04.00013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pathways, 2018. Verfasst von Philip Cyr und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cyr, P., & Blandford, L. (2018). Economic Assessment of Novel Gene and Cellular Therapies: Beyond Traditional Modeling. Journal of Clinical Pathways. https://doi.org/10.25270/jcp.2018.04.00013
Vancouver
Cyr P, Blandford L. Economic Assessment of Novel Gene and Cellular Therapies: Beyond Traditional Modeling. Journal of Clinical Pathways. 2018. doi:10.25270/jcp.2018.04.00013
BibTeX
@article{Cyr2018,
author = {Cyr, Philip and Blandford, Larry},
title = {Economic Assessment of Novel Gene and Cellular Therapies: Beyond Traditional Modeling},
journal = {Journal of Clinical Pathways},
year = {2018},
doi = {10.25270/jcp.2018.04.00013}
}
EUVIMED